Abstract:Abstract Sex-determining region Y-box2 (SOX2), a master regulator of embryonic and induced pluripotent stem cells, drives cancer stem cells (CSCs) properties, fuels tumor initiation, and contributes to tumor aggressiveness. Our previous study has demonstrated the oncogenic role of SOX2 in colorectal cancer (CRC). In this study, we sought to elucidate the underlying mechanisms. Cell function experiments were performed to detect chemoresistance, proliferation, stemness, migration, and invasion in vitro. Chromatin immunoprecipitation, co-immunoprecipitation, luciferase reporter assay, and immunofluorescence were performed to explore the regulation of ABCC2, β-catenin, and Beclin1 by SOX2. The carcinogenic role of SOX2-β-catenin/Beclin1-ABCC2 axis in vivo was analyzed by CRC tissues and xenograft models. Here, we reported that SOX2 sustained chemoresistance by transcriptional activation of ABCC2 expression. Suppressing either β-catenin or autophagy signaling curbed SOX2-driven chemoresistance, stemness, and epithelial–mesenchymal transition (EMT). Mechanistically, SOX2 combined with β-catenin and increased its nuclear expression and transcriptional activity. Transcriptional activation of Beclin1 expression by SOX2 consequently activating autophagy and inducing malignant phenotype. Furthermore, overexpression of β-catenin or Beclin1 facilitated ABCC2 expression. The clinical analyses showed that high expression of ABCC2 and Beclin1 were positively correlated with SOX2 and were associated with poor prognosis in CRC patients. Finally, xenograft models revealed that inhibition of SOX2 expression and autophagy restrained tumor growth and chemoresistance in vivo. Conclusively, we demonstrated a novel mechanism by which the SOX2-β-catenin/Beclin1/autophagy signaling axis regulates chemoresistance, stemness, and EMT in CRC. Our findings provide novel insights into CRC carcinogenesis and may help develop potential therapeutic candidates for CRC.

Autophagy regulates the cancer stem cell phenotype of head and neck squamous cell carcinoma through the noncanonical FOXO3/SOX2 axis

Autophagy-Related Beclin 1 and Head and Neck Cancers

Autophagy augments the self-renewal of lung cancer stem cells by the degradation of ubiquitinated p53

Autophagy Maintains the Stemness of Ovarian Cancer Stem Cells by FOXA2.

SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial–mesenchymal transition by β-catenin and Beclin1/autophagy signaling in colorectal cancer

Autophagic responses to hypoxia and anticancer therapy in head and neck cancer

The Hippo Effector TAZ Promotes Cancer Stemness by Transcriptional Activation of SOX2 in Head Neck Squamous Cell Carcinoma

Autophagy Contributes to the Survival of CD133+ Liver Cancer Stem Cells in the Hypoxic and Nutrient-Deprived Tumor Microenvironment

Decrease of autophagy activity promotes malignant progression of tongue squamous cell carcinoma.

Tumor growth suppression by inhibiting both autophagy and STAT3 signaling in HNSCC.

Identification of Autophagy-Related Genes for Regulating Cancer Stem Cell Characteristics in Colon Adenocarcinoma by the Analysis of Transcriptome Data Stemness Indices

Beclin 1 and Autophagy Are Required for the Tumorigenicity of Breast Cancer Stem-Like/progenitor Cells

Pluripotency transcription factors and cancer stem cells: small genes make a big difference

SOX4 maintains the stemness of cancer cells via transcriptionally enhancing HDAC1 revealed by comparative proteomics study

Unveiling the Noncanonical Autophagy-Independent Role of ATG7 and ATG9B in Head and Neck Squamous Cell Carcinoma (HNSCC)

Role of hypoxia inducible factor-1 in cancer stem cells

Targeting an Autocrine Regulatory Loop in Cancer Stem-like Cells Impairs the Progression and Chemotherapy Resistance of Bladder Cancer.

Autophagy Contributes to the Enrichment and Survival of Colorectal Cancer Stem Cells under Oxaliplatin Treatment

MAP4K4 mediates the SOX6-induced autophagy and reduces the chemosensitivity of cervical cancer

Regulation of the proline regulatory axis and autophagy modulates stemness in TP73/p73 deficient cancer stem-like cells

LIMP-2 Enhances Cancer Stem-Like Cell Properties by Promoting Autophagy-Induced GSK3β Degradation in Head and Neck Squamous Cell Carcinoma